Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous ThrombosisThalia S. Field, Kenneth Butcher, Vanessa Dizonno et al.|Stroke|2023Cited by 70
Anticoagulation practice patterns in COVID‐19: A global surveyRachel Rosovsky, Lisa Baumann Kreuziger, Surbhi Shah et al.|Research and Practice in Thrombosis and Haemostasis|2020Cited by 45